 Your new post is loading...
Your new post is loading...
|
Scooped by
Gilbert C FAURE
September 5, 2012 3:07 AM
|
Opposing ViewsFDA Approves New Drug "Bosulif" for Chronic Myelogenous LeukemiaOpposing Views“With the approval of tyrosine kinase inhibitors, we are seeing improvements in the treatment of CML based on a better understanding of the molecular basis...
|
|
Scooped by
Gilbert C FAURE
September 4, 2012 2:08 PM
|
BiolineRX will develop and commercialize Biokine's Phase II drug for acute myeloid leukemia (AML), and other types of hematological cancer - its first-ever cancer treatment (BiolineRX licenses Clal Biotech unit leukemia drug
|
|
Scooped by
Gilbert C FAURE
September 4, 2012 8:16 AM
|
treatment of Acute Myeloid Leukemia (AML) and a solution to the high rate of disease relapse experienced by patients. The study identified a protein interaction that limits the immune response to AML and provides a method ...
|
|
Scooped by
Gilbert C FAURE
September 3, 2012 6:27 AM
|
Abstract. Cancer stem cells (CSC; also called tumor-initiating cells) comprise tumor cell subpopulations that preserve the properties of quiescence, self-renewal, and differentiation of normal stem cells.
|
|
Scooped by
Gilbert C FAURE
September 3, 2012 6:23 AM
|
Novartis drug JakaviR first medication to receive European Commission ...ReutersOne patient in each group discontinued treatment for thrombocytopenia or for anemia, respectively.
|
|
Scooped by
Gilbert C FAURE
September 1, 2012 6:22 AM
|
Ariad Pharmaceuticals Inc. said the European Union’s drug regulator has granted its request for accelerated assessment of its new cancer medicine, which may lead to a faster approval.
|
|
Scooped by
Gilbert C FAURE
September 1, 2012 6:21 AM
|
There's a chance in a million that a patient on a bone marrow waiting list finds someone compatible. HEALTH looks into the different donating techniques and sees the disparities in Europe and the Middle East.
|
|
Scooped by
Gilbert C FAURE
August 31, 2012 3:04 PM
|
ALN Magazine is a publication of resources, products, and information to design, build, and equip today's research animal facilities. Animal Lab News.
|
|
Scooped by
Gilbert C FAURE
August 30, 2012 3:33 PM
|
This report analyzes the worldwide markets for Acute Myeloid Leukemia (AML) Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World.
|
Scooped by
BENE
August 30, 2012 5:18 AM
|
In the case of leukemias, Stanford researchers finally have an answer to the first question: Mutations accumulate slowly in blood stem cells, the cells that produce all the cells of the blood and immune system.
|
|
Scooped by
Gilbert C FAURE
August 27, 2012 2:39 PM
|
(Medical Xpress)—University of Rochester Medical Center scientists believe they are the first to identify genes that underlie the growth of primitive leukemia stem cell, and then to use the new genetic signature to identify ...
|
|
Scooped by
Gilbert C FAURE
August 26, 2012 2:09 PM
|
Philadelphia InquirerIrena G. Koprowska | pathology professor, 95Philadelphia InquirerDr.
|
|
Scooped by
Gilbert C FAURE
August 24, 2012 2:47 PM
|
Biology of Blood and Marrow Transplantation, Volume 18, Issue 9, Pages 1329-1340, September 2012, Authors:Cédric Carli; Martin Giroux; Jean-Sébastien Delisle (Roles of Transforming Growth Factor-β in Graft-versus-Host and Graft-versus-Tumor Effects...
|
|
|
Scooped by
Gilbert C FAURE
September 4, 2012 2:09 PM
|
A team of scientists led by a bone marrow transplant researcher at Fred Hutchinson Cancer Research Center has shed new light on why most bone marrow transplant patients who receive tissue-matched cells from unrelated donors still suffer acute...
|
|
Scooped by
Gilbert C FAURE
September 4, 2012 2:07 PM
|
This page is your resource for information on all types of leukemia, lymphoma, myeloma, myelodysplastic syndromes and myeloproliferative diseases. (Did you know, September is National Blood Cancer Month.
|
|
Scooped by
Gilbert C FAURE
September 3, 2012 2:11 PM
|
Promising method of growing blood cells in the lab (Promising method of growing blood cells in the lab: A team of scientists from Albert Einstein Col...)...
|
|
Scooped by
Gilbert C FAURE
September 3, 2012 6:25 AM
|
Mutation Linked to Rare LymphomaMedPage TodayMononuclear cells from 21 patients with IgM MGUS and from 15 healthy individuals also were sequenced.
|
|
Scooped by
Gilbert C FAURE
September 1, 2012 6:23 AM
|
RT @ahhajeer: Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia http://t.co/k99MJBkt...
|
|
Scooped by
Gilbert C FAURE
September 1, 2012 6:21 AM
|
MedPage TodayFDA Approves Short-Acting Neutropenia DrugMedPage Today"Supportive care products, such as tbo-filgrastim, reduce or allow for more rapid recovery from side effects of cancer treatments," Richard Pazdur, MD, director of the FDA Office...
|
|
Scooped by
Gilbert C FAURE
August 31, 2012 3:11 PM
|
Gene Matching May Cut AML RelapseMedPage TodayA study of KIR genes in AML patients undergoing stem-cell transplant from unrelated donors found that KIR2DS1, which activates natural killer cells, was associated with a decreased chance of leukemia...
|
|
Scooped by
Gilbert C FAURE
August 31, 2012 3:02 PM
|
RT @ASH_hematology ASH Honors @bcmhouston Margaret A.
|
|
Scooped by
Gilbert C FAURE
August 30, 2012 11:48 AM
|
Particular Donor Genotype Lowers Leukemia Relapse RateDoctors LoungePatients with acute myeloid leukemia who receive a stem cell transplant from a donor with activating killer-cell immunoglobulin-like receptor genotype KIR2DS1, which has ligand...
|
|
Scooped by
BENE
August 30, 2012 4:05 AM
|
FDA approves new treatment for severe neutropenia in certain cancer patientsFDA.govTbo-filgrastim is intended for use in adults who have cancers other than blood or bone marrow cancers (non-myeloid malignancies) and are taking chemotherapy drugs that...
|
|
Scooped by
Gilbert C FAURE
August 26, 2012 2:36 PM
|
RT @VonneMonai: Sickle Cell Anemia Declared Global Health Problem / Treatment News / News / CheckOrphan http://t.co/KxueQtOG...
|
|
Scooped by
Gilbert C FAURE
August 24, 2012 2:48 PM
|
Talon Therapeutics' Marqibo (vinCRIStine sulfate LIPOSOME injection) received accelerated approval from the U.S. Food and Drug Administration (FDA) for the.
|
Scoop.it!
